Infliximab in pediatric Crohn disease patients with enterovesicular fistulas.
Teitelbaum
Jonathan E
JE
Pediatric Gastroenterology and Nutrition, The Children's Hospital at Monmouth Medical Center, Long Branch, NJ 08008, USA. jteitelbaum@sbhcs.com
Saeed
Shehzad
S
Triantafyllopoulou
Maria
M
Daum
Frederic
F
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002648:Child; D003424:Crohn Disease / Q000150:complications*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D007412:Intestinal Fistula / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D016896:Treatment Outcome; D001747:Urinary Bladder Fistula / Q000188:drug therapy* / Q000209:etiology
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab